CJ Bioscience, Inc. (KOSDAQ: 311690)

CJ Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	42,226	64,095	49,324	62,060	13,255	5,354
Short-Term Investments	-	-	-	18,020	-	-
Trading Asset Securities	-	-	-	-	26,020	25,732
Cash & Short-Term Investments	42,226	64,095	49,324	80,080	39,275	31,086
Cash Growth	8.97%	29.95%	-38.41%	103.89%	26.35%	188.69%
Accounts Receivable	197.49	160.91	303.82	233.62	99.46	96.3
Other Receivables	393.4	178.66	523.06	474.16	257.47	97.79
Receivables	590.89	339.57	826.88	707.78	356.93	194.09
Inventory	250.21	157.82	76.16	145.83	364.31	98.67
Prepaid Expenses	830.51	355.71	446.57	259.18	499.9	126.59
Other Current Assets	295.91	262.22	258.72	362.03	592.63	136.89
Total Current Assets	44,193	65,210	50,932	81,555	41,089	31,642
Property, Plant & Equipment	9,821	12,707	14,364	9,856	19,991	1,728
Long-Term Investments	2	2	2	0	-	0
Other Intangible Assets	12,461	12,397	1,016	114.13	103.95	126.11
Other Long-Term Assets	862.57	811.16	25,075	24,830	12,178	244.86
Total Assets	67,340	91,128	91,389	116,355	73,362	33,741
Accounts Payable	272.03	122.82	336.65	287.75	708.93	288.86
Accrued Expenses	3,399	3,966	3,996	140.94	169.76	137.66
Short-Term Debt	5,120	3,971	23,588	18,441	-	-
Current Portion of Leases	1,856	1,869	1,547	1,361	205.9	370.01
Other Current Liabilities	3,580	4,793	5,511	3,606	1,919	1,508
Total Current Liabilities	14,227	14,722	34,979	23,836	3,004	2,305
Long-Term Debt	-	-	-	-	35,081	-
Long-Term Leases	1,537	2,692	3,831	4,088	479.37	368.16
Other Long-Term Liabilities	3,110	2,152	2,924	577.4	314.4	213.6
Total Liabilities	19,271	19,633	41,734	28,502	38,878	2,887
Common Stock	4,556	4,556	2,939	2,937	1,946	1,904
Additional Paid-In Capital	151,426	151,426	108,066	112,186	40,993	31,780
Retained Earnings	-109,345	-85,951	-62,738	-28,035	-8,763	-4,222
Comprehensive Income & Other	1,432	1,465	1,389	765.25	307.61	1,393
Shareholders' Equity	48,069	71,496	49,655	87,853	34,484	30,855
Total Liabilities & Equity	67,340	91,128	91,389	116,355	73,362	33,741
Total Debt	8,513	8,533	28,966	23,891	35,766	738.17
Net Cash (Debt)	33,713	55,562	20,357	56,190	3,509	30,348
Net Cash Growth	12.05%	172.93%	-63.77%	1501.15%	-88.44%	181.83%
Net Cash Per Share	3697.33	7843.75	3463.50	13214.21	908.96	9191.08
Filing Date Shares Outstanding	9.11	9.11	5.88	5.87	3.89	3.81
Total Common Shares Outstanding	9.11	9.11	5.88	5.87	3.89	3.81
Working Capital	29,967	50,488	15,953	57,718	38,085	29,337
Book Value Per Share	5275.11	7845.89	8446.71	14957.10	8859.45	8100.57
Tangible Book Value	35,609	59,098	48,640	87,739	34,380	30,729
Tangible Book Value Per Share	3907.67	6485.40	8273.89	14937.67	8832.74	8067.46
Land	-	-	-	-	13,973	-
Buildings	-	-	-	-	2,563	-
Machinery	-	13,686	10,339	4,411	3,488	3,206
Construction In Progress	-	-	521.7	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.